No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

British Journal of Nutrition

Volumn 99, Issue 2, 2008, Pages 421-431

  Rogers, Peter J ^a   Appleton, Katherine M ^a   Kessler, David ^a   Peters, Tim J ^a   Gunnell, David ^a   Hayward, Robert C ^a   Heatherley, Susan V ^a   Christian, Leonie M ^a   Mcnaughton, Sarah A ^b   Ness, Andy R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Cognitive function; Depressed mood; DHA; EPA

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID PLUS ICOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; OLIVE OIL; PLACEBO; TOCOPHEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEPRESSION ANXIETY AND STRESS SCALE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AFFECT; COGNITION; DEPRESSION; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 38049182755     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507801097     Document Type: Article

References (54)

1. Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl, 560S-569S.
2. SACN/COT (2004) Advice on Fish Consumption: Benefits and Risks. London: TSO.
3. Hibbeln JR & Salem N (1995) Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J Clin Nutr 62, 1-9.
4. Peet M, Glen I & Horrobin DF (1999) Phospholipid Spectrum Disorder in Psychiatry. Carnforth Lancashire: Marius Press.
5. Rogers PJ (2001) A healthy body, a healthy mind: Long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60, 135-143.
6. Hallahan B & Garland MR (2004) Essential fatty acids and their role in the treatment of impulsivity disorders. Prost Leuk Ess Fatty Acids 71, 211-216.
7. Murray CJL & Lopez AD (1996) The Global Burden of Disease. Cambridge MA: Harvard School of Public Health.
8. Chalon S, Delion-Vancassel S, Blezung C, Guilloteau D, Leguisquet AM, Besnard JC & Durand G (1998) Dietary fish oil affects monoaminergic neurotransmission and behaviour in rats. J Nutr 128, 2512-2519.
9. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC & Chalon S (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41, 32-40.
10. Adams PB, Lawson S, Sanigorski A & Sinclair AJ (1996) Arachidonic to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depressed mood. Lipids 31, S167-S176.
11. Peet M, Murphy B, Shay J & Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43, 315-319.
12. Maes M, Christophe A, Delanghe J, Altamura C, Neels H & Meltzer HY (1999) Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiat Res 85, 275-291.
13. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ & Breteler MM (2003) Plasma fatty acid composition and depression are associated in the elderly: The Rotterdam Study. Am J Clin Nutr 78, 40-46.
14. Mamalakis G, Tornaritis M & Kafatos A (2002) Depression and adipose essential polyunsaturated fatty acids. Prost Leuk Ess Fatty Acids 67, 311-318.
15. Noaghiul S & Hibbeln JR (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 160 2222-2227.
16. Silvers KM & Scott KM (2002) Fish consumption and self-reported physical and mental health status. Public Health Nutr 5, 427-431.
17. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J & Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatric Services 52, 529-531.
18. Appleton KM, Peters TJ, Hayward RC, Heatherley SV, McNaughton SA, Gunnell D, Rogers PJ, Ness AR & Kessler D (2007) Depressed mood and n3 polyunsaturated fatty acid intake from fish: Non-linear or confounded association? Soc Psychiatry Psychiatr Epidemiol 42, 100-104.
19. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D & Lonnqvist J (2004) Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161, 567-569.
20. Ellis FR & Sanders TA (1977) Long-chain polyunsaturated fatty acids in endogenous depression. J Neurol Neurosur Psychiatry 40, 168-169.
21. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D & Ness AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J Clin Nutr 84, 1308-1316.
22. Lovibond PF & Lovibond SH (1995) The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck depression and anxiety inventories. Behav Res Therapy 33, 335-343.
23. Winkler D, Pjrek E & Kasper S (2005) Anger attacks in depression: evidence for a male depressive syndrome. Psychother Psychosom 74, 303-307.
24. Austin MP, Mitchell P & Goodwin GM (2001) Cognitive deficits in depression: Possible implications for functional neuropathy. Brit J Psychiatry 178, 200-206.
25. Kalmijn S, van Boxtel MJP, Ocké M, Verschuren WMM, Kromhout D & Launer LJ (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62, 275-280.
26. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S & Lodi L (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35, 691-699.
27. Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B & Meltzer H (1997) The National Psychiatric Morbidity Surveys of Great Britain: initial findings from the Household Survey. Psychol Med 27, 755-789.
28. Lovibond SH & Lovibond PF (1995) Manual for the Depression Anxiety and Stress Scales. Sydney: Psychology Foundation of Australia Inc.
29. Beck AT & Steer RA (1987) Beck Depression Inventory Manual. San Antonio, Texas: Psychological Corporation.
30. Goldberg D & Williams P (1988) A User's Guide to the General Health Questionnaire. Basingstoke, Hampshire: NFER-Nelson Publishing.
31. Spielberger CD (1991) State-Trait Anger Expression Inventory: Professional Manual. Odessa, Florida: Psychological Assessment Resources Inc.
32. Polet P, Rogers PJ, Wardle J, Atkinson EA, Vallis L, Rapoport L, Taylor M & Judd P (1998) Mood effects of reduced-fat dietary treatment. Proc Nutr Soc 57, 83A.
33. MacLeod C & Mathews A (1988) Anxiety and the allocation of attention to threat. Q J Exp Psychol 40, 653-670.
34. Mogg K & Bradley BP (2005) Attentional bias in generalized anxiety disorder versus depressive disorder. Cognitve Ther Res 29, 29-45.
35. Rogers PJ, Heatherley SV, Hayward RC, Seers HE, Hill J & Kane M (2005) Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep deprivation. Psychopharmacology 179, 742-752.
36. Brown RG, Scott LC, Bench CJ & Dolan RJ (1994) Cognitive function in depression: Its relationship to the presence and severity of intellectual decline. Psychol Med 24, 829-847.
37. Weschler D (1997) Weschler Adult Intelligence Scale, 3rd ed., San Antonio, TX: Psychological Corporation.
38. Baddeley A (1986) Working Memory. Oxford: Clarendon Press.
39. Rabbitt P, Donlan C, Watson P, McInnes L & Bent L (1995) Unique and interactive effects of depression, age, socio-economic advantage and gender on cognitive performance of normal healthy older people. Psychol Aging 10, 307-313.
40. Sackeim HA, Keilp JG, Rush AJ, et al. (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatr Neuropsychol Behav Neurol 14, 53-62.
41. Burdge GC, Wright P, Jones AE & Wootton SA (2000) A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Brit J Nutr 84, 781-787.
42. Silvers KM, Woolley CC, Hamilton FC, Watts PM & Watson RA (2005) Randomized double-blind placebo-controlled trial of fish oil in the treatment of depression. Prost Leuk Ess Fatty Acids 72, 211-218.
43. Nemets B, Stahl Z & Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477-479.
44. Peet MB & Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913-919.
45. Su K-P, Huang S-Y, Chiu C-C & Shen WW (2003) Omega-3 fatty acids in major depressive disorder - a preliminary double-blind placebo-controlled trial. Eur Neuropsychopharm 13, 267-271.
46. Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM & Renshaw PF (2004) Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry 161, 1922-1924.
47. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK & Marangell LB (1999) Omega-3 fatty acids in bipolar disorder - a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56, 407-412.
48. Fenton WS, Dickerson F, Boronow J, Hibbeln JR & Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158, 2071-2074.
49. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC & Heird WC (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 1348-1353.
50. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Seung Kim HF & Puryear LJ (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996-998.
51. Ness AR, Gallacher JEJ, Bennett PD, Gunnell DJ, Rogers PJ, Kessler D & Burr ML (2003) Advice to eat fish and mood: A randomised controlled trial in men with angina. Nutr Neurosci 6, 63-65.
52. Zanarini MC & Frankenburg MD (2003) Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind placebo-controlled pilot study. Am J Psychiat 160, 167-169.
53. Frangou S, Lewis M & McCrone P (2006) Efficacy of ethyleicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. Brit J Psychiatry 188, 46-50.
54. Nemets H, Nemets B, Apter A, Bracha Z & Belmaker RH (2006) Omega-3 treatment of children's depression: A controlled, double-blind pilot study. Am J Psychiatry 163, 1098-1100.